Suppressor of cytokine signaling (SOCS)5 ameliorates influenza infection via inhibition of EGFR signaling
Kedzierski, L
Tate, MD
Hsu, AC
Kolesnik, TB
Linossi, EM
Dagley, L
Dong, Z
Freeman, S
Infusini, G
Starkey, MR
Bird, NL
Chatfield, SM
Babon, JJ
Huntington, N
Belz, G
Webb, A
Wark, PA
Nicola, NA
Xu, J
Kedzierska, K
Hansbro, PM
Nicholson, SE
- Publication Type:
- Journal Article
- Citation:
- eLife, 2017, 6
- Issue Date:
- 2017-02-14
Open Access
Copyright Clearance Process
- Recently Added
- In Progress
- Open Access
This item is open access.
Full metadata record
Field | Value | Language |
---|---|---|
dc.contributor.author | Kedzierski, L | en_US |
dc.contributor.author | Tate, MD | en_US |
dc.contributor.author | Hsu, AC | en_US |
dc.contributor.author | Kolesnik, TB | en_US |
dc.contributor.author | Linossi, EM | en_US |
dc.contributor.author | Dagley, L | en_US |
dc.contributor.author | Dong, Z | en_US |
dc.contributor.author | Freeman, S | en_US |
dc.contributor.author | Infusini, G | en_US |
dc.contributor.author | Starkey, MR | en_US |
dc.contributor.author | Bird, NL | en_US |
dc.contributor.author | Chatfield, SM | en_US |
dc.contributor.author | Babon, JJ | en_US |
dc.contributor.author | Huntington, N | en_US |
dc.contributor.author | Belz, G | en_US |
dc.contributor.author | Webb, A | en_US |
dc.contributor.author | Wark, PA | en_US |
dc.contributor.author | Nicola, NA | en_US |
dc.contributor.author | Xu, J | en_US |
dc.contributor.author | Kedzierska, K | en_US |
dc.contributor.author |
Hansbro, PM https://orcid.org/0000-0002-4741-3035 |
en_US |
dc.contributor.author | Nicholson, SE | en_US |
dc.date.available | 2017-02-06 | en_US |
dc.date.issued | 2017-02-14 | en_US |
dc.identifier.citation | eLife, 2017, 6 | en_US |
dc.identifier.uri | http://hdl.handle.net/10453/126211 | |
dc.description.abstract | © Kedzierski et al. Influenza virus infections have a significant impact on global human health. Individuals with suppressed immunity, or suffering from chronic inflammatory conditions such as COPD, are particularly susceptible to influenza. Here we show that suppressor of cytokine signaling (SOCS) five has a pivotal role in restricting influenza A virus in the airway epithelium, through the regulation of epidermal growth factor receptor (EGFR). Socs5-deficient mice exhibit heightened disease severity, with increased viral titres and weight loss. Socs5 levels were differentially regulated in response to distinct influenza viruses (H1N1, H3N2, H5N1 and H11N9) and were reduced in primary epithelial cells from COPD patients, again correlating with increased susceptibility to influenza. Importantly, restoration of SOCS5 levels restricted influenza virus infection, suggesting that manipulating SOCS5 expression and/or SOCS5 targets might be a novel therapeutic approach to influenza. | en_US |
dc.relation.ispartof | eLife | en_US |
dc.relation.isbasedon | 10.7554/eLife.20444 | en_US |
dc.subject.mesh | Animals | en_US |
dc.subject.mesh | Mice, Knockout | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Mice | en_US |
dc.subject.mesh | Influenza A virus | en_US |
dc.subject.mesh | Orthomyxoviridae Infections | en_US |
dc.subject.mesh | Disease Models, Animal | en_US |
dc.subject.mesh | Body Weight | en_US |
dc.subject.mesh | Receptor, Epidermal Growth Factor | en_US |
dc.subject.mesh | Cytokines | en_US |
dc.subject.mesh | Viral Load | en_US |
dc.subject.mesh | Signal Transduction | en_US |
dc.subject.mesh | Suppressor of Cytokine Signaling Proteins | en_US |
dc.subject.mesh | ErbB Receptors | en_US |
dc.title | Suppressor of cytokine signaling (SOCS)5 ameliorates influenza infection via inhibition of EGFR signaling | en_US |
dc.type | Journal Article | |
utslib.citation.volume | 6 | en_US |
utslib.for | 1101 Medical Biochemistry and Metabolomics | en_US |
utslib.for | 0601 Biochemistry and Cell Biology | en_US |
pubs.embargo.period | Not known | en_US |
pubs.organisational-group | /University of Technology Sydney | |
pubs.organisational-group | /University of Technology Sydney/Faculty of Science | |
pubs.organisational-group | /University of Technology Sydney/Faculty of Science/School of Life Sciences | |
utslib.copyright.status | open_access | |
pubs.publication-status | Published | en_US |
pubs.volume | 6 | en_US |
Abstract:
© Kedzierski et al. Influenza virus infections have a significant impact on global human health. Individuals with suppressed immunity, or suffering from chronic inflammatory conditions such as COPD, are particularly susceptible to influenza. Here we show that suppressor of cytokine signaling (SOCS) five has a pivotal role in restricting influenza A virus in the airway epithelium, through the regulation of epidermal growth factor receptor (EGFR). Socs5-deficient mice exhibit heightened disease severity, with increased viral titres and weight loss. Socs5 levels were differentially regulated in response to distinct influenza viruses (H1N1, H3N2, H5N1 and H11N9) and were reduced in primary epithelial cells from COPD patients, again correlating with increased susceptibility to influenza. Importantly, restoration of SOCS5 levels restricted influenza virus infection, suggesting that manipulating SOCS5 expression and/or SOCS5 targets might be a novel therapeutic approach to influenza.
Please use this identifier to cite or link to this item:
Download statistics for the last 12 months
Not enough data to produce graph